Veradermics MANE
NYSE MANE
$139.11 +0.73 (+0.53%)
At close: Oct 23, 2026 · 4:00 PM EDT

Veradermics (MANE) Cash & Current Investments (2024 - 2026)

Updated

Veradermics' Cash & Current Investments came in at $819.89 million for Q2 2026, up 109.8% from the prior quarter.

Analysis

Veradermics (MANE) Cash & Current Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics' Cash & Current Investments was $141.86 million, up 167.2% from FY2024.

  • Going back by year, Cash & Current Investments was $53.08 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Veradermics 5.81 Bn 4.41 Bn - 819.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 819.89 Mn
Mar 31, 2026 390.80 Mn
Dec 31, 2025 141.86 Mn
Dec 31, 2024 53.08 Mn
API Access

Veradermics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MANE&period=max&api_key=YOUR_API_KEY